Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?

BACKGROUND: Iran is one of the countries with a high prevalence of multiple sclerosis (MS) and COVID-19.MS patients receiving the immunomodulatory or immunosuppressive therapy have a higher risk of infection. Due to the significance of determining the risk factors for getting COVID-19 among MS patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Naser Moghadasi, Abdorreza, Shabany, Maryam, Heidari, Hora, Eskandarieh, Sharareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883704/
https://www.ncbi.nlm.nih.gov/pubmed/33631509
http://dx.doi.org/10.1016/j.clineuro.2021.106563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883704/
https://www.ncbi.nlm.nih.gov/pubmed/33631509
http://dx.doi.org/10.1016/j.clineuro.2021.106563

Ejemplares similares